Your browser doesn't support javascript.
loading
Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer: phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis.
Labidi-Galy, S I; Rodrigues, M; Sandoval, J L; Kurtz, J E; Heitz, F; Mosconi, A M; Romero, I; Denison, U; Nagao, S; Vergote, I; Parma, G; Nøttrup, T J; Rouleau, E; Garnier, G; El-Balat, A; Zamagni, C; Martín-Lorente, C; Pujade-Lauraine, E; Fiévet, A; Ray-Coquard, I L.
Affiliation
  • Labidi-Galy SI; Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland; Department of Medicine, Division of Oncology, Faculty of Medicine, University of Geneva, Swiss Cancer Center Leman, Geneva, Switzerland. Electronic address: intidhar.labidi-galy@hcuge.ch.
  • Rodrigues M; INSERM U830, Institut Curie, PSL Research University, Paris, Paris, France; Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France; ARCAGY-GINECO, Paris, France.
  • Sandoval JL; Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland; Department of Medicine, Division of Oncology, Faculty of Medicine, University of Geneva, Swiss Cancer Center Leman, Geneva, Switzerland.
  • Kurtz JE; ARCAGY-GINECO, Paris, France; ICANS (Institut de Cancérologie Strasbourg Europe), Strasbourg, France.
  • Heitz F; Department of Gynecology & Gynecologic Oncology, Ev. Kliniken Essen-Mitte, Essen, Germany; AGO, Berlin; Charité-Universitätsmedizin Berlin, Campus Virchow, Berlin, Germany.
  • Mosconi AM; S.C. di Oncologia Medica Osp., S. Maria della Misericordia-AO di Perugia, Perugia, Italy; MITO, Italy.
  • Romero I; Instituto Valenciano de Oncología, Valencia, Spain; GEICO, Spain.
  • Denison U; Institute for Gynaecological Oncology und Senology-Karl Landsteiner, Klinik Hietzing, Vienna, Austria; AGO, Austria.
  • Nagao S; Hyogo Cancer Center, Hyogo, Japan; Okayama University Hospital, Okayama, Japan.
  • Vergote I; University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium; BGOG, Belgium.
  • Parma G; Istituto Europeo Oncologia, Milan, Italy; MANGO, Italy.
  • Nøttrup TJ; Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; NSGO, Denmark.
  • Rouleau E; Department of Medical Biology and Pathology, Cancer Genetics Laboratory, Gustave Roussy, Villejuif, France.
  • Garnier G; Centre Hospitalier Princesse Grace, Monaco; GINECO, Monaco.
  • El-Balat A; Charité-Universitätsmedizin Berlin, Campus Virchow, Berlin, Germany; Spital Uster, Frauenklinik, Uster, Switzerland; Klinikum der Johann Wolfgang Goethe-Universität Frankfurt, Klinik für Frauenheilkunde und Geburtshilfe, Frankfurt, Germany.
  • Zamagni C; IRCCS Azienda Ospedaliero-universitaria di Bologna, Bologna, Italy.
  • Martín-Lorente C; GEICO, Spain; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Pujade-Lauraine E; ARCAGY-GINECO, Paris, France; ICANS (Institut de Cancérologie Strasbourg Europe), Strasbourg, France.
  • Fiévet A; Department of Medical Biology and Pathology, Cancer Genetics Laboratory, Gustave Roussy, Villejuif, France.
  • Ray-Coquard IL; ARCAGY-GINECO, Paris, France; ICANS (Institut de Cancérologie Strasbourg Europe), Strasbourg, France; Centre Léon Bérard, Lyon, France; Health Services and Performance Research Lab (EA 7425 HESPER), University Claude Bernard Lyon, Lyon, France.
Ann Oncol ; 34(2): 152-162, 2023 02.
Article in En | MEDLINE | ID: mdl-36564284
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Risk_factors_studies Limits: Female / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Risk_factors_studies Limits: Female / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2023 Type: Article